1. Home
  2. Community
  3. Promotions
  4. COVID-19 Research Funding Support

With the rapid spread of COVID-19, countries worldwide have joined the war against the SARS-CoV-2 virus. As a leading provider of animal models with a strong basis in social responsibility – Cyagen’s research and development (R&D) team continues to make every effort to help research progress through developing both animal models and technical resources catered to the global SARS-CoV-2/COVID-19 research initiative.


When applying for COVID-19 research funding, reviewers will seek to understand the strategies used in generating any research models for your proposal. Cyagen’s model generation experts can provide you with a letter of support for your project, clarifying the key significance of the custom model for your research – easing reviewer concerns.


When it comes to your COVID-19/SARS-CoV-2 grant funding applications, Cyagen has your back.

How can Cyagen help you?
  • ■  Targeting strategies provided within 48 hours of request
  • ■  Detailed quotes with estimated turnaround times for your grant applications
  • ■  Free project consultation from our scientists
  • ■  Price matching policy: we’ll match competitors with an additional 5% discount
  • ■  Complimentary Research Project (R01) grant support letter
Funding Opportunities for COVID-19/SARS-CoV-2 Research

There are a growing number of funding mechanisms geared towards improving the understanding of clinical outcomes SARS-CoV-2 infections and COVID-19 disease. Genomic studies utilizing model systems to study consequences of SARS-CoV-2 infection are of particular interest, with supported research expected to guide future efforts in diagnosis, prevention, mitigation, and treatment of this viral infection. The National Institutes of Health (NIH) and related organizations have issued several notices of special interest (NOSI) to highlight the urgent need for research on COVID-19. Many additional funding agencies and commercial entities continue to unite behind the need for research to continue.


In addition to searching for research funds through the usual methods, the unique situation continues to generate opportunities from new sources. Johns Hopkins University has compiled a regularly-updated resource page for US researchers to easily access COVID-19 funding opportunities:

Cyagen Coronavirus Research News & Updates

1. ACE2 Mice – Expedite Your COVID-19 Research Efforts


Cyagen is prioritizing production of ACE2 mice to support research on COVID-19, the disease caused by SARS-CoV-2 virus. Effective immediately, Cyagen is opening orders on models for ACE2 receptor targets, including humanized, knockout (KO), and ROSA26 knockin (KI) mouse models.

Catalog Models Estimated Availability Backgrounds Price ($) per Mouse
ACE2 Knockout (KO) As Fast as 4 Months C57BL/6J $500
BALB/c $650
Humanized Mice (ROSA26 cKI) As Fast as 4 Months C57BL/6J $1000
BALB/c $1300
Humanized Mice (Endogenous Replacement) As Fast as 4 Months C57BL/6J $1200
BALB/c $1500

For more information, visit: ACE2 Mice – Expedite Your COVID-19 Research Efforts


Contact Our Animal Model Experts for Funding Support
If you have any questions, please feel free to contact us by email at animal-bank@cyagen.com or by phone at 800-921-8930 (8-6pm PST) in the US or +1 408-969-0306 (Int'l).

Please fill in the following fields:

Your Name can not be empty

Your Tel can not be empty

Please enter a valid phone number

Your Email can not be empty

Please enter a valid email address

Your Institution can not be empty

Your Detailed request can not be empty

We will contact you within 1-2 working days!

Knockout Mice | Ready-to-Use KO Mice Model